Obesity is a risk factor for colorectal cancer (CRC), accounting for more than 14% 13 of CRC incidence. Microbial dysbiosis and chronic inflammation are common 14 characteristics in both obesity and CRC. Human and murine studies, together, 15 demonstrate the significant impact of the microbiome on governing energy 16 metabolism and CRC development; yet, little is understood about the contribution 17 of the microbiome to development of obesity-associated CRC as compared to non-18 obese individuals. In this study, we conducted a meta-analysis using five publicly 19 available stool and tissue-based 16S rRNA and whole genome sequencing (WGS) 20 data sets of CRC microbiome studies. High-resolution analysis was employed for 21 16S rRNA data using Resphera Insight, which allowed us to achieve species-level 22 information to compare with WGS. Characterization of the confounders between 23 studies, 16S rRNA variable region, and sequencing method, did not reveal any 1 significant effect on alpha diversity in CRC prediction. Both 16S rRNA and WGS 2 were equally variable in their ability to predict CRC. Results from community 3 structure and composition analysis confirmed lower diversity in obese individuals 4 without CRC; however, no universal differences were found in diversity between 5 obese and non-obese individuals with CRC. When examining taxonomic 6 differences, the probability of being classified as CRC did not change significantly 7 in obese individuals for all taxa tested. However, random forest classification was 8 able to distinguish CRC and non-CRC stool when body mass index was added to 9 the model. Overall, microbial dysbiosis was not a significant factor in explaining the 10 higher risk of colon cancer among individuals with obesity. 11
incidence (1, (3) (4) (5) . Alarmingly, incidence and mortality from CRC is on the rise 1 among those under the age of 55 (SEER), possibly due to the significant increase 2 in obesity in women (6) . For these reasons, it is imperative to identify new methods 3 to reduce the burden of obesity on the risk and mortality from colon cancer. Three 4 areas of inquiry are important for understanding the etiology of CRC: obesity, 5 inflammation, the microbiome. 6
Several studies indicate that specific microbial taxa are playing a role in the 7 etiology of colon cancer. However, whether the microbiome is also contributing to 8 development of obesity-associated colon cancer in humans is completely 9 unknown. One method that has shown promise for identifying early stage colon 10 cancer is through analyzing the microbiome of the gastrointestinal tract (GI). The 11 structure and function of the bacterial community that makes up the human colon, 12 in part, determines the function and health of the colonic epithelium, as well as, the 13 immune system responses. Several studies have found colon cancer-associated 14 microbiota in pre-cancerous colon tissue (adenomas). Further, the microbiome has 15 been used to distinguish pre-cancerous adenomas from CRC, though with variable 16 rates of accuracy (7-9). Several bacteria have been identified as promoters in 17 colon cancer development, including enterotoxigenic Bacteroides fragilis and 18 Fusobacterium nucleatum (10) (11) (12) (13) (14) . Both have also been isolated from patients with 19 familial adenomatous polyposis (FAP) or inflammatory bowel disease, which are 20 risk factors for colon cancer (11, 15) . Colorectal adenocarcinomas associated with 21 high abundance of fecal F. nucleatum, specifically, were found to have the highest 22 number of somatic mutations, suggesting that these mutations create a pathogen-23 friendly environment (16, 17) . In animal models of colon cancer, inoculation of 1 germ-free animals with stool from tumor-bearing animals were found to have more 2 tumors than mice inoculated with stool from tumor-free animals (18). More 3 recently, colonic biofilms from individuals with familial adenomatous polyposis 4 were found to be dominated by E. coli and B. fragilis biofilms and enriched with 5 genotoxic colibactin and B. fragilis toxin (ETBF) genes (11) . 6
Multiple lines of evidence demonstrate that both diet and obesity can 7 significantly alter the microbiome (19) (20) (21) (22) (23) (24) (25) . One of the first seminal studies illustrating 8 the impact of the microbiome on obesity, transferred the fecal microbiota from 9 monozygotic twins who were obese or lean to germ-free mice. From this study, they 10 were able to recapitulate the obesity phenotype in humanized mice (26) . When 11 examining microbiota and subsequent changes in metabolism after fecal transfer from 12 obese mice to germ-free mice, it was found that this obesogenic microbial community 13 had an increased production of SCFAs, which was later shown to abrogate lipid 14 storage (23, 26) . Multiple follow-up studies in obese and lean individuals have linked 15 the specific shift in the microbiota to the ratio of Bacteroides:Firmicutes (25, 27, 28) . 16
However, a recent meta-analysis of these studies indicate that this ratio is not 17 sufficient to differentiate obese from lean individuals in separate studies. Thus, more 18 research is necessary to identify the microbiome-host relationship in individuals with 19 obesity (29, 30) . 20
Chronic inflammation is a hallmark of both obesity and CRC etiology. Obesity 21 is characterized by pro-inflammatory adipose tissue macrophages that secrete high 22 levels of IL-17, a cytokine which is also induced by ETBF in murine models of colon 23 cancer (10, 31, 32) . Given the reciprocal relationship between the microbiome and 1 the immune system, it is logical to hypothesize that obesity-associated microbial 2 dysbiosis, combined with a state of chronic inflammation, contributes to the increased 3 risk of colon cancer among obese individuals. In support of this hypothesis, animal 4 models of colon cancer (Apc 1638N ), have demonstrated that a high fat diet or 5 genetically (ob/ob) induced obesity can significantly alter the microbiome leading to a 6 loss of Parabacteroides distasonis and an increase in pro-inflammatory factors (22) . 7
In a separate model of colon cancer (K-ras G12Dint ), fecal transfer from high-fat fed mice 8 with intestinal tumors to genetically susceptible mice on a standard diet replicated the 9 disease phenotype (33). Thus, it appears that a high fat diet may be sufficient to 10 change the microbiome into a tumor-promoting community independent of obesity 11 and glucose response. Intriguingly, Akkermansia muciniphila, which is reduced in 12 obese individuals and is associated with epithelial barrier function, is paradoxically 13 higher in CRC (34, 35) . This data, together with evidence that A. muciniphila can 14 modulate glucose metabolism and inflammation in the colon, suggests it may play a 15 role in obesity-associated CRC (35, 36) . As these data demonstrate, there are a 16 variety of dysbiotic states that exist in obese individuals, which could further enhance 17 the inflammatory state of the GI tract leading to an increased risk of CRC. No human 18 studies to date have addressed the obesity-associated differences in the microbiome 19 and its relationship to CRC however. 20 In this study, we utilized multiple publicly available data sets in which either 21 stool or tissue microbiome sequencing was conducted, and from which body mass 22 index (BMI) was also available. Using the bioinformatics tools QIIME (16S rRNA) and 23 Pathoscope (WGS), we processed the 16S rRNA and WGS reads, and derived a 1 taxonomic profile from each of the samples. Furthermore, we inferred taxonomic 2 function to assess potential metabolic differences in obese individuals with CRC. We 3 used these taxa and the metabolic pathway information to determine if a taxonomic 4 signature or if specific taxa were associated with both obesity and CRC. From this 5 analysis, we observed that the dysbiosis associated with obesity was independent 6 from the dysbiosis associated with CRC. 7 METHODS 8
Sample Population 9
For this study we identify studies relevant to assess the relationship between 10 obesity and CRC using the microbiome as the independent variable using the following 11 search terms in PubMed ((((("humans OR "microbiome"[All Fields]))) AND (("colonic neoplasms"[MeSH Terms] OR 16 ("colonic"[All Fields] AND "neoplasms"[All Fields]) OR "colonic neoplasms"[All Fields] 17 OR ("colon"[All Fields] AND "cancer"[All Fields]) OR "colon cancer"[All Fields]) OR 18 ("colorectal neoplasms"[MeSH Terms] OR ("colorectal"[All Fields] AND "neoplasms"[All 19
Fields]) OR "colorectal neoplasms"[All Fields] OR ("colorectal"[All Fields] AND 20 "cancer"[All Fields]) OR "colorectal cancer"[All Fields]) OR CRC[All Fields]) 21
. From our PubMed search we identified 5 (out of 124) studies that met all of our 22 criteria: primary research in a human population, colon or colorectal cancer AND 23 normal stool or tissue collected, raw sequences available from either 16S rRNA or 1 WGS sequencing, body mass index available as a variable in the metadata including 2 age and sex. Together, 5 studies were identified that assessed both BMI and the 3 microbiome in stool or tissue from individuals with adenomas, carcinomas or 4 individuals without disease ( Table 1) . Three of these studies conducted 16S rRNA 5 sequencing on stool or tissue, and 3 conducted WGS on stool or tissue, with one 6 utilizing RNA sequencing. One study conducted both 16S rRNA and WGS on tissue 7 and stool. 8
Processing of Microbial Reads and Calculation of Diversity 9
All sequence data were downloaded from the NCBI Sequence Read Archive. In order to 10 eliminate differences between studies, we processed the reads using the same 11 methods, either QIIME plus the algorithm Resphera Insight for 16S rRNA sequencing or 12
Pathoscope (v1.0) for processing WGS or RNA-seq reads. For the studies sequencing 13 the 16S rRNA gene, the V4 region was used for all stool samples, as well as, tissue, 14 with the exception of the subsample of tissue from another study used as part of the 15 Zeller et al. 2014 data set. Details regarding sequencing methods and variable regions 16 amplified for each data set are listed in Table 1 . 17
Raw paired-end reads reflecting 16S rRNA fragments were merged into consensus 18 sequences using FLASH (min overlap: 20 bp overlap; 5% max mismatch density), and 19 trimmed for quality (target error rate < 1%) using Trimmomatic and QIIME. PhiX control 20 sequences were identified using BLASTN and filtered. Resulting sequences were 21 evaluated for chimeras with UCLUST (de novo mode) and screened for human DNA 22
using Bowtie2 against NCBI Homo sapiens Annotation Release 106. Reads assigned to 23 chloroplast or mitochondrial contaminants by the RDP classifier with a minimum 1 confidence of 50% were also removed. High-quality 16S rRNA sequences were 2 assigned to a high-resolution taxonomic lineage using Resphera Insight (37-39) 3
Raw paired-end shotgun metagenomics sequence datasets were also trimmed for 4 quality using Trimmomatic (min final length 75bp) and screened for human genomic 5 DNA using Bowtie2 (--sensitive setting against GRCh38 reference with alternate 6 chromosomes). High-quality passing sequences were submitted to Pathoscope v1.0 7 for species level characterization (40, 41) . 8 9
Prediction of Metagenomic Pathways 10
We utilized two methods in order to derive abundance of metabolic pathways 11 from the 16S rRNA or WGS sequences. For the 16S rRNA reads, after obtaining the 12 OTU tables, we utilized the PICRUSt algorithm. This method obtains the 13 representative genomes according the nearest neighbor match, and then normalizes 14 the genome abundance using the 16S rRNA copy number for that genome. Once the 15 metagenomics content is binned, it is expressed in terms of KEGG representative 16 ortholog (KO) counts. For the WGS reads, we utilized the HUMAnN algorithm. This 17 method takes as input short DNA or RNA reads and uses BLAST to identify 18 orthologous gene families, which are used to identify metabolic pathways. Once 19 identified, the pathways are then normalized by presence/absence of the taxa, and 20 additionally by relative abundance of the taxa present in the sample. These data were 21 used for downstream statistical analysis to compare obese and normal stool samples 22 from individuals with or without CRC. 23
Statistical Analyses 1
Prior to analysis we rarefied the data to the sample with the lowest 2 number of reads. In order to test the association between BMI and the microbiome, we 3 grouped our statistical analyses into four subgroups: A) normal stool samples (healthy 4 controls), B) CRC stool or CRC tissue, and C) pooled samples (healthy controls and 5 CRC), all of which were adjusted for age and sex. Group C was further adjusted for 6 disease status. 7
For alpha diversity measurements, we used both the observed number of OTUs 8 and the Shannon Index. To determine associations with BMI, we treated it as a 9 continuous variable (as a covariate) in the main analysis. For additional analyses, we 10 also dichotomized the subjects into non-obese (BMI < 30) and obese (BMI >= 30) 11 according the WHO guidelines. 12
For beta diversity measurements, we utilized four distance measurements 13 unweighted UniFrac, weighted UniFrac, generalized UniFrac and Bray-Curtis for 16S 14 datasets. For WGS/RNA-seq data, where we do not have the phylogenetic tree, we 15 instead used two non-tree-based distance measurements Jensen-Shannon and Bray-16 Curtis (42). Different distance measurements represent different views of the microbial 17 community and multiple distance measurements are used to have a more 18 comprehensive view. In order to determine the difference in community membership 19 between BMI categories, we used the PERMANOVA test on single distance 20 measures, with the omnibus test on the combination of all distance metrics 21 (PermanovaG, 'GUniFrac' R package) (43). 22
In order to compare taxonomic abundance between groups, we used as input OTU 1 counts. Negative binomial regression was used with BMI as a continuous variable for 2 analysis of the microbiome while controlling for age and sex. Using multilevel 3 modeling, the effects of confounders in study designs are examined. In this multilevel 4 model, the study is defined as level 2 and the individual observations are level 1. At 5 level 1, the outcome is CRC status (1=has CRC, 0=does not) and is predicted by an 6 intercept, alpha diversity and BMI. At level 2, the level 1 regression coefficients (i.e. 7 β0j, β1j, and β2j for the intercept, alpha diversity and BMI regression coefficient, 8 respectively) are modeled by the study characteristics. In this model, the level 1 9 regression coefficients vary among studies, which means, for example, that the effect 10 of alpha diversity to predict CRC status varies by study and study characteristics. For 11 precisely, we are estimating the following model: 12
Where the regression coefficients are modeled by study characteristics. For 14 example, 23 = 22 + 25 ( ℎ ) + 2A ( ) + 23 ; which 15 defines how the model parameter vary by study characteristics. In this model, the 's 16
represent the level two model parameters and u is the study specific error term. 17 Estimation of this model is employed using the lme4 (linear mixed effects) package in 18 R (44). Due to the few number of studies included in this meta-analysis, the estimation 19 of the variance of the level 1 parameters is uncertain and should be interpreted with 20
caution. 21
In order to compare taxonomic abundance between groups, we used as input 22
OTU counts. Negative binomial regression was used with BMI as a continuous 23 variable (obese vs. non-obese) for analysis of the microbiome while controlling for age 1 and sex. Multiple testing procedure was conducted on these values using BH-based 2 false discovery rate control. The criterion to declare significance was q-value <0.2 . 3
Furthermore, the abundance of Bifidobacterium catenulatum was examined among 4 groups of obese or non-obese individuals with and without CRC. The standardized 5 mean differences among studies was calculated using Hedge's g, a bias corrected 6 estimate of standardized mean differences. Estimation was employed using the meta 7 package in R (45). 8
Mediation analyses were also conducted. The goal of these analyses is to 9 uncover if the relationship between BMI and CRC status is mediated by bacteria 10 present. First, bacteria were dummy coded for presence or not for everyone. By 11 dummy coded solely for whether an individual has a given bacteria or not, these 12 results are not meant to show mediation among varying levels of each bacterium. 13
Second, the relationship between BMI and CRC status was estimated by using a 14 simple logistic regression model. Third, the classic mediation model was estimated by 15 using the lavaan package in R (46). This model is estimated for the presence of each 16 bacterium. Lastly, the change in the odd ratio is calculated between models. The 17 change in the OR is an estimate of the mediation effect that a bacterium has on the 18 relationship between BMI and CRC status. 19
Further exploration of whether taxonomic abundance among obese or non-20 obese individuals is indicative of CRC utilized random forest analyses. Random forest 21 analysis is a machine learning/predictive modeling algorithm designed to estimate an 22 ensemble of decision trees that are combined to give an estimate of an output. In this 23 study, we employed random forest analyses as a classification of obesity (obese vs. 1 non-obese) conditional on the status of CRC. Four random forests were grown for 2 each study dataset when possible; the forests were grown using the relative 3 abundance of taxa with or without age and sex included at the OTU and genus level 4 for two subsets of data that were conditioned on CRC status (CRC or adenoma). The 5 resulting models aimed to classify individuals as obese based on the microbiota 6 composition, and these classification models were tested with 10-fold cross validation. 7
The receiver-operating-curve (ROC) of these classifications was also inspected for 8 how sensitive the models are to detect obese individuals and how specific these 9 models are to select only individuals that are obese. A measure of model quality is the 10 area under curve (AUC), or area under the ROC, where an AUC of one is perfect 11 prediction and an AUC of .5 is pure chance or prediction. Another benefit of using 12 random forest analyses is that an estimate of the predictive importance of each OTU 13 or genera is estimated. This estimate of importance is found by the predictive quality of 14 model conditional of the ensemble trees that do not contain that specific input variable 15 (OTU or genera in this case). All processed data and code for this analysis has been 16 deposited at: https://github.com/GreathouseLab/CRC_BMI_meta_analysis. 17
Results 18
Database and study selection. We performed a systematic review and meta-analysis 19 guided search of the literature. Within this search we included studies that analyzed 20 the microbiome of the stool or tissue from patients with colon cancer, and which also 21 had clinical information from patients on BMI. From this initial search, we identified 24 22 studies. After eliminating studies in which BMI information could not be obtained, 5 23 studies were included in the final analysis ( Table 1) . Given that our central hypothesis 1 is predicated on a difference in microbial structure and composition between obese 2 and non-obese individuals, we focused our initial analyses on the Baxter et al. study, 3 which has adequate sample size to detect differences between these two groups (8). 4
The remaining studies were used as comparators to support or negate any 5 associations found between the microbiome and obesity. 6
Characterization of cofounders between studies. A major issue facing microbiome 7 studies is the lack of standardized methods for collection, storage, nucleotide 8 extraction, sequencing methodology and bioinformatic analysis. Thus, we began our 9 analysis by characterizing the effect of 16S rRNA variable region and sequencing 10 methods (16S rRNA or WGS) on observed OTUs and Shannon diversity on prediction 11 of CRC. Unfortunately, we could not fully test the effect of nucleotide extraction as the 12
Feng et al. study did not provide this information. We chose to focus on alpha 13 diversity for this analysis given that it is a low-resolution measure, which allows for 14 comparison across studies. Using multilevel modeling to predict CRC status we 15 calculated the average log2 OR (logit) for each study when these level 2 predictors 16 (variable region and sequencing method) are included in the model. The results of this 17 analysis demonstrated that alpha diversity and obesity vary by study but do not 18 significantly change the probability of having CRC ( Figure 1A-B ; Figure S1 ). 19
Interestingly, the Feng et al. data set display an unusual inverse relationship between 20 CRC ad BMI that strongly impacts prediction of CRC, possibly due to geographic and 21 dietary differences in this population. Since all but one of the studies used the V4 16S 22 rRNA region, it was difficult to determine if this variable had a significant impact. 23
Between the studies that used different extraction techniques, Zeller (GNOME DNA 1 Isolation Kit, MP Biomedical) vs Baxter and Zackular et al.(Power Soil, Mo Bio) , we 2 did not observe an effect of extraction technique on the relationship between alpha 3 diversity and probability of CRC ( Figure 1A-B ). Further, the predictive ability of 16S 4 rRNA data, alpha diversity, to classify CRC varies among studies but using WGS does 5 not improve this predicative ability nor does variable region choice ( Figure 1A-B ). 6
Overall, among the potential confounders we tested, we did not observe a significant 7 effect on the ability of alpha diversity to classify CRC cases and controls when 8 controlling for obesity. 9
Alpha Diversity Analysis. We next sought to validate previous studies showing 10 differences in alpha diversity between obese and non-obese individuals without CRC. 11
In order to analyze alpha diversity within each sample study population, we calculated 12 both richness, observed OTUs, and Shannon diversity, which considers both 13 evenness and richness. We conducted linear modeling analysis using BMI as a 14 continuous measurement and calculated the observed OTUs and Shannon diversity 15 controlling for age and sex. Confirming previous microbial studies of stool from healthy 16 (non-CRC) individuals (30), we also found significantly lower Shannon diversity in 17 individuals that are obese without cancer from two of the 16S rRNA data sets (Baxter Mann-Whitney U tests did not show this same result comparing individuals with and 20 without obesity ( Fig. 2A ; Supplemental Fig S2A and Table 2 ). Supporting previous 21 meta-analyses, however, studies with N<100 subjects displayed similar trends but did 22 not reach statistical significance. When we asked if this same trend of lower Shannon 23 diversity was present in obese individuals with CRC, we saw no association, with the 1 exception of the Feng dataset, which demonstrated a significantly higher alpha 2 diversity with higher BMI both as continuous and categorical models, but not in the 3 unadjusted analysis ( Fig. 2B ; Supplemental Fig S2B and Table 2 ). These results may 4 be due to geography and diet of Asian populations. We chose not to analyze the 5 Bacteroides/Firmicutes ratio as this has not demonstrated to be a consistent 6 measurement of predicting obesity in human studies (30). Together, these data 7 indicate that while there is an association between community composition and obesity 8 in those without CRC, this association is not present in those with both obesity and 9
CRC. 10
Beta Diversity Analysis. We next asked whether we could detect microbial 11 community differences in structure between obese and normal weight individuals with 12 or without CRC. In order to conduct this analysis, we calculated the distance matrix for 13 each study using UniFrac or Bray-Curtis (BC) for 16S rRNA datasets, and BC or 14 Jaccard-Sorrensen (JS) distance for WGS datasets. Further, we calculated the 15 omnibus p-value for comparison of all distance matrices (47). In all of the data sets rRNA/tissue), we observed a significant difference (omnibus p-value <0.05) in 18 community structure between obese and non-obese individuals without CRC (Table 3 ; 19 see community composition. Thus, similar to community composition, community structure 1 is associated with BMI in individuals without CRC but not in those with CRC. 2 Taxonomic Diversity Analysis. Again, we began our taxonomic analysis comparing 3 individuals with and without obesity among individuals without CRC as a means of 4 validating previous studies, using as our reference the largest study dataset, Baxter et 5 al. (8) . From this analysis, controlling for age and sex, a significantly lower relative 6 abundance of several Ruminiococcus spp. was identified in the two of the datasets 7 Table  12 1). When combining all differentially significant species, those from genus Bacteroides 13
and Bifidobacteria appeared most often to differentiate individuals with and without 14 obesity (Supplemental Table 1 ). While no one genera or species was found to be 15 differentially abundant (higher or lower) between all 5 datasets comparing individuals 16 with or without obesity among individuals without CRC, the genus Bacteroides 17 contained the greatest number of differentially abundant species in individuals with 18 obesity in all but one dataset (Supplemental Table 1 ). 19 20 Mediation effect of differentially abundant taxa on obesity-associated CRC 21 classification. In order to determine if any taxa were affecting (mediating) the 22 relationship between BMI and CRC probability, we took two approaches. The first 23 approach was a classical mediation test, in which we constructed three tests. First, we 1 estimated the odds-ratio (OR) of individuals with higher BMI being more likely to be 2 classified as having CRC. Second, we estimated the same relationship between BMI 3 and CRC status while controlling for the mediating effect of differentially abundant 4 bacteria. Meaning, if the bacterium mediates the relationship between BMI and CRC 5 probability then the OR for BMI will decrease. Third, we calculated how much change 6 in the OR occurred from the first to second model. Thus, from this change in ORs, we 7 estimated how much of an effect including each taxa had on increasing or decreasing 8 the probability of being classified as CRC for each one unit increase in BMI. From this 9 analysis, we identified several taxa that increased or decreased the probability of CRC 10
( Supplemental Tables 2-3 ). Species from the Bacteriodes, Ruminococcus and 11
Prevotella genera, as well as, Bifidobacterium catenulatum decreased the probability 12 of CRC with increasing BMI, except for two species of Prevotella which increased 13 CRC probability. The mediation effect of these taxa, however, was relatively weak; 14 less than 1% change in OR (change in probability of CRC, OR range = -9e-05 --0.01) 15 were approximately based on 1 -(1 -q1)*(1-q2), where q1 and q2 are q values for the 1 BMI and DS associations on the pooled data set (q value can be interpreted as the 2 probability of being false positive, 1 -(1 -q1)*(1-q2) is the probability of being false 3 positive in either of the associations, assuming independence between the two tests). 4
The q-values were calculated for each data set, and q-values for taxa <20% were 5 considered to have a significant mediating effect. Using this approach, we looked for 6 taxa that had a significant mediating effect between studies and identified two, 7
Phascolarctobacterium succinatutens and Streptococcus salivarius; however, they 8 were only shared between 2/6 studies each ( Supplemental Table 4 ). Overall, these 9 results indicate the majority of bacteria associated with CRC and BMI decrease the 10 odds of CRC in individuals with obesity, but only weakly. 11
In addition, to determine if previously identified CRC-associated taxa, F. nucleatum, F. 12 prausnitzii, B. fragilis, or A. muciniphila, were altered in individuals with obesity in their 13 ability to differentiate CRC from non-CRC, we calculated the log2 odds ratios for each 14 species. ( Supplementary Fig. S5 ). Overall, among individuals with obesity, F. 15 nucleatum consistently showed stronger prediction (log2 OR) of CRC. 16
Ability of the microbiome to classify obesity-associated CRC. Given that previous 17 studies have demonstrated the predicative capability of the microbiome in generating 18 classifiers for CRC, we next asked whether a taxonomic consortium could accurately 19 predict obesity-associated CRC. Using the machine learning method random forest, 20
we calculated importance scores among obese individuals at the OTU or genus level 21 using 10-fold cross-validation in individuals with adenomas or CRC. These values 22
were then used to calculate area under the receiver operator curve using age and sex 23 as co-variates or the microbiome alone. Among all obese individuals, the average of 1 all AUC values predicting CRC cases at the OTU and genus level was 0.66 ( classifier, we choose to apply the same method (48) entire community. Thus, we interrogated the metabolic potential of the bacterial 23 community using the bioinformatics tool PICRUSt in order to obtain predicted 1 functions. Among individuals without CRC, we identified biotin synthesis and biotin 2 metabolism inversely correlated with BMI in the Vogtmannn (WGS) stool samples, and 3 the urea cycle (M0029) inversely correlated with BMI in both Vogtmannn (WGS) and 4
Feng (WGS) ( Figure 4A-B ). However, none of these predicted functions differentiated 5 obese individuals among all studies. When we conducted this analysis in individuals 6 with CRC, no shared correlations were identified when comparing obese and non-7 obese. Predicted functional analysis therefore, did not further distinguish obesity-8 associated CRC from those with CRC and normal BMI. 9
Discussion. 10
Evidence clearly demonstrates an intimate link between inflammation, obesity, and 11 the microbiome (34, 36, (49) (50) (51) (52) (53) (54) (55) (56) . In vivo, multiple studies indicate an interaction or 12 mediating effect of the microbiome in promoting colon tumorigenesis in the presence 13 of a high-fat diet or genetic-induced obesity (21, 22, (57) (58) (59) . In this study, using BMI as 14 a measure of obesity, we were able to initiate the first analysis addressing this 15 outstanding question in human subjects. 16 This is the most comprehensive high-resolution study of the microbiome in 17 individuals with and without obesity among those with CRC, using multiple sequencing 18 platforms and methods. In this meta-analysis, we describe both obesity-and CRC-19 associated results. First, we found both community structure and composition in stool 20 and tissue samples from individuals with CRC are independent of BMI. Second, we 21 identified a weak effect of the majority of species associated with both BMI and CRC 22 on risk of CRC. Lastly, we show the microbiome, by itself or modeled with age and 23 sex, is insufficient to classify adenomas or CRC from obese controls. However, when 1 controlling for clinical variables and BMI, we are able to achieve similar levels of CRC 2 classification to other studies (48). Overall, by combining species-level resolution from 3 16S rRNA and WGS data, we were able to define the microbial community structure 4 and function at a high resolution, revealing overall a weak effect of the microbiome on 5 mediating CRC risk among individuals with obesity as compared to those with normal 6
BMI. 7
While this study did not identify any strong universal BMI-associated microbial 8 biomarkers of CRC, many mechanisms are likely key in driving the increased risk of 9 CRC in obese individuals that we could not account for in this study. These include 10 tumor location (left vs right), mutation profile, differentiation, mismatch repair status, 11 and diet; some of which have shown to differentiate individuals with obesity among 12 those with CRC (60-63). A high fat diet may be more important than BMI or obesity in 13 driving the deleterious changes in the microbiome in individuals with obesity. In 14 support, feeding a high-fat diet to K-ras G12Dint mice is sufficient to drive tumorigenesis 15 from 30% to 60% (33). Moreover, when feces from high fat fed mice (K-ras G12Dint ) are 16 transferred to healthy (K-ras G12Dint ) mice, tumor burden is increased along with 17 diminished immune cell recruitment (33). This was prevented, however, when 18 supplemented with butyrate, which also increased Bifidobacterium abundance as 19 compared to mice not supplemented with butyrate (33). We also found several species 20 of Bifidobacterium lower in individuals with obesity among those with and without 21 CRC. Interestingly, butyrate and butyrate producing bacteria were shown to be 22 increased in African-American men after switching to a traditional high fiber, low-fat 23 rural African diet (64). Again, similar to the results of high-fat feeding promoting CRC, 1 which was abrogated with butyrate treatment, the aforementioned study found that the 2 high-fat Western diet of African-Americans was associated with higher secondary bile 3 acids, known promoters of carcinogenesis. Together, these studies indicate that a high 4 fat diet, specifically from saturated fats, may be interacting with the microbiome to 5 create a pro-inflammatory environment conducive to colon carcinogenesis. 6
Other possible mechanisms explaining the increased risk of CRC in individuals with 7 obesity include a lack of balance in key immune regulatory cells, specifically regulatory 8 T cells (Tregs) and B lymphocytes. Demonstration that Tregs are important in 9 promoting colon tumorigenesis, indicates that species that can control their activation 10 may be important in controlling CRC development. Specifically, when B. 11 pseudocatenulatum (CECT 7765) was given orally to obese mice, it increased Tregs 12 and reduced pro-inflammatory cytokines (IL-17A and TNF-a), which further supports 13 the hypothesis that certain species may protect against chronic inflammation and 14 development of CRC (51). In reports measuring dietary inflammatory factors (empirical 15 dietary inflammatory pattern), individuals with higher inflammatory scores had fewer 16 tumor-associated adaptive anti-tumor immune cells suggesting immune evasion (65). 17
Moreover, using this same approach, higher inflammatory scores were associated with 18 higher tumor-associated F. nucleatum in CRC (66). Again, these findings support a 19 distinct influence of diet on the microbiome in CRC development apart from obesity. 20 BMI is crude measure of obesity, and other more accurate measures (e.g. waist 21 circumference, adipokines, etc.) are required to fully explore the relationship between 22 obesity, inflammation, and the microbiome in development of CRC. An exemplar of 23 this relationship is demonstrated for lung cancer, wherein the use of BMI demonstrates 1 a lower risk of lung cancer is associated with higher BMI but use of waist 2 circumference or waist to hip ratio demonstrates and increased risk of lung cancer 3 (67). Thus, this study sets the stage for future research to consider adding measures 4 of adiposity beyond BMI when studying the etiology and risk of CRC, as well as, other 5 cancers influenced by obesity. 6
This study has several strengths, as well as, limitations. One important strength, 7 was the ability to use multiple peer-reviewed studies that had similar study designs 8 and sequencing methods. As the Microbiome Quality Control Project demonstrated, 9 multiple factors (e.g. DNA extraction method) can contribute to differential findings 10 between studies, and thus our ability to control for these confounding factors reduced 11 this bias (68-71). Also, the ability to confirm the presence of multiple taxa using 12 separate sequencing methods, 16S rRNA and WGS methods, further strengthened 13 the design of this analysis. The limitations of this study include small sample sizes in 14 the majority of studies, use of only one anthropometric measurement of obesity and 15 lack of other informative factors including dietary fat intake, previous weight loss prior 16 to CRC diagnosis, microbial metabolites and biofilm presence. Sample size is a key 17 limitation when looking at the relationship between obesity (BMI) and the microbiome 18 as previously demonstrated (30). Only the Baxter (8) study was sufficiently powered to 19 detect a significant difference in the microbial community between normal and obese 20 individuals. While we were able to identify taxa that differentiated obese and normal 21 individuals with CRC in this study specifically, these taxa were not consistent across 22
all studies, indicating that other factors such as metabolites, biofilm or the immune 23 system are stronger contributors to this relationship. While we were able to derive 1 inferred function from the microbial sequences, without more intensive direct 2 measurement of the metabolites (i.e. mass spectrometry), we cannot fully assess 3 these differences. Additionally, studies have illustrated this lack of relationship 4 between specific taxa and CRC, and instead identified a stronger association with the 5 presence of biofilm formation. Lastly, animal studies demonstrating that CRC 6 promotion by a high fat diet was independent of obesity supports our findings and 7 suggests that dietary fat has a greater impact than obesity on the microbiome and its 8 tumor-promoting capacity in CRC etiology. This will therefore be important to consider 9 in the obesity-CRC relationship in future research. 10
Overall, our validation of microbiome-based classifiers indicates this approach, in 11 combination with FOBT or FIT tests, is well supported for continued development. 12
More important, these data along with other studies indicate that diet, rather than 13 obesity, is creating a pro-inflammatory microbial community increasing CRC risk. 14 Hence, characterizing the role of the diet in addition to the microbiome in CRC etiology 15 is necessary, which will require more detailed molecular analyses and well-designed 16 longitudinal human studies to identify early stage dietary and microbial biomarkers 17 prior to disease. 18
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Figure 2:
Alpha diversity in individuals with or without obesity and with or without CRC A) Observed OTUs and Shannon diversity in individuals without CRC B) or with CRC comparing individuals with or without obesity. Reporting p-values are from Mann-Whitney U Test comparing the alpha diversity of individuals with or without obesity.
Figure 3:
Microbial classifiers of CRC and obesity-associated CRC. A) Receiver Operating Curve (ROC) for the random forest classification analyses for obese vs. non-obese in individuals with CRC for each study. AUC is the 10-fold cross validated area under the curve. B) ROC for the random forest classification analyses of obese vs. non-obese in individuals with adenomas for each study. Due to a lack of cases with adenomas in some studies a random forest was not possible and are therefore not shown. C) ROC for the random forest classification analyses of CRC vs non-CRC in each dataset adjusted for BMI, age and sex.
Figure 4:
Pathway abundance analysis in individuals with or without obesity among individuals with or without CRC. Relative abundance of KEGG metabolic pathways (16S rRNA) or modules (WGS) inferred from PICRUSt or HUMAnN, respectively. Significance was calculated using the Wilcox test correction for multiple hypothesis testing; asterisks are representative of significance at adjusted p-value <0.2. Figure S1 : Probability of having CRC using alpha diversity as a predictor among individuals with obesity. Predicted probability of having CRC using A) observed OTUs or B) Shannon Index.
Supplemental Figures

Figure S2:
Alpha diversity by BMI in individuals with or without CRC A) Observed OTUs and Shannon diversity in individuals without CRC comparing BMI and alpha diversity metric, observed OTUs or Shannon diversity respectively. B) Observed OTUs and Shannon diversity in individuals with CRC comparing BMI and alpha diversity metric, observed OTUs or Shannon diversity respectively.
Figure S3:
Beta diversity in induvial with or without obesity and with or without CRC A) Differences in community composition between individuals with and without obesity among those without CRC B) or with CRC. The axes were found using PCoA using Bray-Curtis distances among points with the proportion of variance accounted for by each axis reported. Points are colored by obesity status.
Figure S4:
Differential abundance of taxa associated with obesity and CRC taxa. OTUs (16S rRNA) or species (WGS) log 10 scale relative abundance of Ruminiococcus spp., Coprococcus spp., Bacteroides spp., Bifidobacterium spp. and Akkermansia muciniphila. P-values were calculated using negative binomial regression using abundance as a count and including age and sex as covariates. Significant differences between obese v non-obese with or without CRC are denoted by an asterisk (FDR adjusted p-value <0.1)
Figure S5:
Ability of CRC-associated taxa to predict CRC among individuals with obesity. For each species identified from previous CRC microbiome studies , F. nucleatum, F. prausnitzii, B. fragilis, or A. muciniphila , the log2 odd ratio was calculated for individuals with obesity to determine odds of being classified as having CRC. Test of the equality of proportion of individuals that are obese vs. non-obese. 
